Related Experiment Videos
Breast cancer: oncogenes and suppressor genes
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Validity of Online Versus In-Clinic Self-Reported Everyday Cognition Scale.
The journal of prevention of Alzheimer's disease·2022
A retrospective analysis comparing set up errors from standard versus customised headrests for head and neck radiotherapy.
Radiography (London, England : 1995)·2022
Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups.
AJNR. American journal of neuroradiology·2021
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A Multimodal Deep Learning Model for Preoperative Prediction of Postoperative Complications in Gastric Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Arctigenin discovered by high-throughput screening ameliorates doxorubicin-induced cardiotoxicity as a novel natural KEAP1-NRF2 inhibitor.
Journal of pharmaceutical analysis·2026